Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001477932-17-002513
Filing Date
2017-05-23
Accepted
2017-05-23 17:21:30
Documents
64
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A biei_10qa.htm 10-Q/A 20109
2 CERTIFICATION biei_ex311.htm EX-31.1 7652
3 CERTIFICATION biei_ex312.htm EX-31.2 7616
4 CERTIFICATION biei_ex321.htm EX-32.1 3550
5 CERTIFICATION biei_ex322.htm EX-32.2 3571
  Complete submission text file 0001477932-17-002513.txt   3612203

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT biei-20170331.xml EX-101.INS 984429
7 XBRL TAXONOMY EXTENSION SCHEMA biei-20170331.xsd EX-101.SCH 60304
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE biei-20170331_cal.xml EX-101.CAL 41652
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE biei-20170331_def.xml EX-101.DEF 148522
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE biei-20170331_lab.xml EX-101.LAB 224264
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biei-20170331_pre.xml EX-101.PRE 225343
Mailing Address P.O. BOX 31374 EL PASO TX 79930
Business Address P.O. BOX 31374 EL PASO TX 79930 814 786 8849
PREMIER BIOMEDICAL INC (Filer) CIK: 0001515740 (see all company filings)

EIN.: 272635666 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54563 | Film No.: 17864714
SIC: 2836 Biological Products, (No Diagnostic Substances)